H.B. Fuller (NYSE:FUL – Get Free Report) is scheduled to post its quarterly earnings results after the market closes on Wednesday, September 27th. Analysts expect H.B. Fuller to post earnings of $1.16 per share for the quarter. H.B. Fuller has set its FY 2023 guidance at $3.80-$4.20 EPS.Parties interested in participating in the company’s conference call can do so using this link.
H.B. Fuller (NYSE:FUL – Get Free Report) last released its earnings results on Thursday, June 29th. The specialty chemicals company reported $0.93 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.04 by ($0.11). The company had revenue of $898.24 million during the quarter, compared to analysts’ expectations of $969.60 million. H.B. Fuller had a net margin of 4.36% and a return on equity of 12.22%. The company’s revenue for the quarter was down 9.6% on a year-over-year basis. During the same quarter last year, the business posted $1.11 earnings per share. On average, analysts expect H.B. Fuller to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.
H.B. Fuller Trading Down 0.7 %
NYSE:FUL opened at $67.99 on Wednesday. The firm has a market cap of $3.66 billion, a PE ratio of 24.02 and a beta of 1.55. The stock has a fifty day moving average price of $71.20 and a 200 day moving average price of $68.03. H.B. Fuller has a 12-month low of $59.31 and a 12-month high of $81.41. The company has a current ratio of 1.99, a quick ratio of 1.24 and a debt-to-equity ratio of 1.10.
H.B. Fuller Dividend Announcement
Wall Street Analyst Weigh In
FUL has been the subject of a number of recent research reports. Citigroup initiated coverage on H.B. Fuller in a report on Monday, September 11th. They issued a “neutral” rating and a $78.00 target price for the company. Stifel Nicolaus lifted their price target on H.B. Fuller from $106.00 to $107.00 and gave the stock a “buy” rating in a report on Friday, June 30th. StockNews.com assumed coverage on H.B. Fuller in a report on Thursday, August 17th. They set a “hold” rating for the company. Robert W. Baird reaffirmed an “outperform” rating and set a $80.00 price target on shares of H.B. Fuller in a report on Friday, June 30th. Finally, JPMorgan Chase & Co. decreased their price target on H.B. Fuller from $66.00 to $60.00 and set an “underweight” rating for the company in a report on Friday, June 30th. One analyst has rated the stock with a sell rating, two have given a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $80.60.
Insider Activity
In other news, CAO Traci L. Jensen sold 22,789 shares of the business’s stock in a transaction dated Wednesday, August 9th. The stock was sold at an average price of $71.47, for a total value of $1,628,729.83. Following the completion of the sale, the chief accounting officer now directly owns 10,576 shares of the company’s stock, valued at approximately $755,866.72. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, VP Robert J. Martsching sold 5,326 shares of the business’s stock in a transaction dated Friday, July 21st. The stock was sold at an average price of $72.24, for a total value of $384,750.24. Following the transaction, the vice president now owns 12,621 shares in the company, valued at approximately $911,741.04. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CAO Traci L. Jensen sold 22,789 shares of the business’s stock in a transaction dated Wednesday, August 9th. The shares were sold at an average price of $71.47, for a total value of $1,628,729.83. Following the completion of the transaction, the chief accounting officer now owns 10,576 shares in the company, valued at approximately $755,866.72. The disclosure for this sale can be found here. In the last three months, insiders sold 50,961 shares of company stock valued at $3,624,198. Insiders own 4.50% of the company’s stock.
Hedge Funds Weigh In On H.B. Fuller
Institutional investors have recently added to or reduced their stakes in the stock. MetLife Investment Management LLC increased its position in H.B. Fuller by 55.7% during the 1st quarter. MetLife Investment Management LLC now owns 27,833 shares of the specialty chemicals company’s stock worth $1,839,000 after purchasing an additional 9,960 shares during the period. Luminus Management LLC acquired a new stake in shares of H.B. Fuller in the 1st quarter worth approximately $3,396,000. UBS Asset Management Americas Inc. grew its holdings in shares of H.B. Fuller by 4.9% in the 2nd quarter. UBS Asset Management Americas Inc. now owns 66,538 shares of the specialty chemicals company’s stock worth $4,006,000 after acquiring an additional 3,081 shares during the period. Eagle Bay Advisors LLC acquired a new stake in shares of H.B. Fuller in the 2nd quarter worth approximately $33,000. Finally, Marshall Wace LLP acquired a new stake in shares of H.B. Fuller in the 3rd quarter worth approximately $701,000. Institutional investors and hedge funds own 94.14% of the company’s stock.
About H.B. Fuller
H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products worldwide. The company operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.
Read More
- Five stocks we like better than H.B. Fuller
- Consumer Staples Stocks, Explained
- Hold-It-Forever AutoZone Pulls into Buy Zone
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Virtual Riches: 3 Stocks Leading the VR Revolution
- How to Invest in Toy Stocks
- 5 eCommerce Companies that need to be on Your Watch List
Receive News & Ratings for H.B. Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H.B. Fuller and related companies with MarketBeat.com's FREE daily email newsletter.
